About Capsy 500 MG Capecitabine Tablets IP
Capsy 500 MG Capecitabine Tablets IP stands as a rare and premier choice among anticancer medications, tailored for those seeking effective solutions against breast and colorectal cancers. Imposing in efficacy yet flawless in form, these special light peach, oval, film-coated prescription tablets each deliver 500 mg Capecitabine for optimal results under physician guidance. Available at a discount for bulk orders from trusted distributors, suppliers, and traders in India, Capsy ensures assured potency, admirable shelf life of 36 months, and steadfast quality in every dose. Storage is simple, yet critical: keep below 30C, shielded from moisture and light.
Unparalleled Advantage and Diverse Application
Capsy 500 MG Capecitabine Tablets IP delivers a significant advantage in the treatment of specific cancers. As a flawless film-coated prescription tablet, it is recommended for adults combating breast and colorectal cancer. Beyond its primary application, Capsy may be integrated within combination chemotherapeutic regimens per physician discretion. Available in user-friendly packs, Capsy serves oncology professionals across clinics, hospitals, and pharmaceutical supply chains, solidifying its role as a versatile, premier medication.
Efficient Delivery, Export Reach, and Supply Capabilities
Capsy 500 MG Capecitabine Tablets IP are estimated to be shipped promptly within agreed timelines, ensuring timely access for patients and professionals. The valuation of Capsy aligns with international quality, making it a compelling choice in premier export markets. Backed by reliable suppliers and a remarkable supply ability, Capsys distribution spans across global networks, facilitating seamless healthcare provisioning, sustained by robust manufacturing capabilities and consistent availability.
FAQs of Capsy 500 MG Capecitabine Tablets IP:
Q: How should Capsy 500 MG Capecitabine Tablets IP be administered?
A: Capsy 500 MG Capecitabine Tablets IP should be taken orally, with water, within 30 minutes after a meal, or as directed by a physician. Strict adherence to prescribed dosage guidelines is essential.
Q: What are the primary indications for using Capsy 500 MG Capecitabine Tablets IP?
A: This medication is recommended primarily for adults in the treatment of breast cancer and colorectal cancer, as part of a comprehensive chemotherapeutic strategy.
Q: When does Capsy 500 MG Capecitabine Tablets IP expire?
A: Capsy maintains its efficacy for 36 months from the manufacturing date, provided it is stored below 30C and protected from moisture and light.
Q: Where is Capsy 500 MG Capecitabine Tablets IP manufactured and supplied from?
A: Capsy is proudly manufactured, distributed, and supplied in India, and is available through approved distributors and suppliers both domestically and in export markets.
Q: What is the process for storing Capsy 500 MG Capecitabine Tablets IP?
A: Store Capsy tablets below 30C, away from direct moisture and light, to maintain the integrity and effectiveness throughout the products shelf life.
Q: Which benefits are associated with Capsy 500 MG Capecitabine Tablets IP?
A: Capsy offers a potent, clinically proven formulation with reliable delivery, making it a trusted option for oncologists and patients seeking effective cancer therapies.